Kleinwort Hambros

WeWork Announces Board Updates

Retrieved on: 
Tuesday, August 8, 2023

“These new director appointments bring a fresh perspective and renewed commitment to the Board and our company,” said David Tolley, Interim Chief Executive Officer of WeWork.

Key Points: 
  • “These new director appointments bring a fresh perspective and renewed commitment to the Board and our company,” said David Tolley, Interim Chief Executive Officer of WeWork.
  • He also serves on the Board of Trustees of Fordham University.
  • Daniel Hurwitz, Vivek Ranadivé and Véronique Laury have stepped down from the Board.
  • The Board is continuing its search for additional independent directors as well as a permanent Chief Executive Officer.

COUR Pharmaceuticals Announces Biotechnology Industry Veteran Robert F. Carey Joins Board of Directors as Lead Independent Director

Retrieved on: 
Wednesday, February 8, 2023

CHICAGO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- COUR Pharmaceuticals, a clinical-stage biotechnology company developing novel immune-modifying nanoparticles designed to reprogram the immune system, today announced the appointment of Robert F. Carey to its board of directors, effective immediately.

Key Points: 
  • CHICAGO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- COUR Pharmaceuticals, a clinical-stage biotechnology company developing novel immune-modifying nanoparticles designed to reprogram the immune system, today announced the appointment of Robert F. Carey to its board of directors, effective immediately.
  • Mr. Carey will serve as COUR’s Lead Independent Director.
  • “We are extremely pleased to welcome Bob Carey to COUR’s board,” said John J. Puisis, Founder & CEO of COUR.
  • I look forward to working closely with John and the COUR team in positioning COUR for tremendous growth and success in the coming years.”

Argo Group Mails Letter to Shareholders Highlighting the Strength of its Refreshed, Highly Qualified Board

Retrieved on: 
Wednesday, November 9, 2022

These qualifications led the Board to appoint him Lead Independent Director upon Mr. Bradleys permanent appointment as CEO.

Key Points: 
  • These qualifications led the Board to appoint him Lead Independent Director upon Mr. Bradleys permanent appointment as CEO.
  • Argos Board and management team have engaged with Capital Returns multiple times, including in meetings with the Board Chairman.
  • The fact is Mr. Bailey purchased more than $90,000 of Argo shares in open market purchases in April 2020 when he joined the Argo Board.
  • Argo undertakes no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise.

SCOR Investment Partners strengthens its real estate private debt investment team

Retrieved on: 
Monday, October 24, 2022

Press release | October 24, 2022

Key Points: 
  • Press release | October 24, 2022
    Supporting the development of its real estate private debt investment strategy, SCOR Investment Partners SE (SCOR IP), the asset management company of the SCOR group, is strengthening its team with the appointment of Pierre Saeli as Head of Real Estate Loans, effective today.
  • A leading player in real estate debt since 2013, SCOR IP's specialized investment team has deployed EUR 2.2 billion across some 80 transactions since inception.
  • Fabrice Rossary, CEO of SCOR Investment Partners, commented: "Pierre Saelis arrival as Head of Real Estate Loans confirms SCOR Investment Partners ambitions and positioning as an expert in private debt especially in fields which are essential to the economy."
  • GP09000006), SCOR Investment Partners has more than 80 employees and is structured around seven management desks: Fixed Income, Corporate Loans, Infrastructure Loans, Direct Real Estate, Real Estate Loans, Insurance-Linked Securities and Fund Selection.

Shineco, Inc. Announces Director Change

Retrieved on: 
Thursday, August 18, 2022

Mr. Quraishi was also appointed to the Companys Audit Committee as well as Chairman of the Companys Nominating Committee.

Key Points: 
  • Mr. Quraishi was also appointed to the Companys Audit Committee as well as Chairman of the Companys Nominating Committee.
  • Since April 2021, Mr. Quraishi has been serving as the Non-Executive Chairman of Bowen Fintech PLC, a London based special-purpose acquisition company.
  • More recently, Mr. Quraishi served as a Managing Director of Teneo Capital LLC (2014-2018), a New York headquartered advisory and investment banking firm where he was responsible for the group's GCC, Africa and Asia coverage.
  • Utilizing modern engineering technologies and biotechnologies, Shineco produces, among other products, Chinese herbal medicines, organic agricultural produce, and specialized textiles.

BTIG Expands Business with Latin America and EMEA Emerging Markets Focus

Retrieved on: 
Tuesday, August 16, 2022

BTIG announced today the expansion of its Fixed Income business to include Latin America and EMEA Emerging Markets to support clients in the region.

Key Points: 
  • BTIG announced today the expansion of its Fixed Income business to include Latin America and EMEA Emerging Markets to support clients in the region.
  • Joining the firm as Managing Directors and Co-Heads of Latin America and EMEA Credit Emerging Markets are Stuart Kasdin and Pablo Melasecca.
  • Matthew Stapen has also been appointed as a Managing Director and Head of Latin America and EMEA Emerging Markets Sales.
  • Earlier in his career, he was a Managing Director, Emerging Markets Sales and a Member of the Emerging Markets Operating Committee at Dresdner Kleinwort Wasserstein.

DEA Appoints Ryohei Nuka, Former Goldman Sachs Vice President Finance, as Its New CFO

Retrieved on: 
Wednesday, August 3, 2022

In 2009, he joined Goldman Sachs and was in charge of product control operations (management accounting and price verification) for the equity and derivatives trading desk.

Key Points: 
  • In 2009, he joined Goldman Sachs and was in charge of product control operations (management accounting and price verification) for the equity and derivatives trading desk.
  • Kyuzaburo Suzuki, its previous CFO, will continue to be involved in the development of our financial strategy as a Senior Advisor.
  • Prior to joining DEA, he was a senior controller in the Finance department of Goldman Sachs Japan.
  • During these critical times, Mr. Nuka's extensive experience at Goldman Sachs will undoubtedly be a great asset to our company.

Global Fintech Leader Zafin Appoints Al-Noor Ramji to Its Board of Directors

Retrieved on: 
Tuesday, June 7, 2022

TORONTO, June 07, 2022 (GLOBE NEWSWIRE) -- Zafin , the worlds leading SaaS cloud-native product and pricing platform, has announced the addition of industry expert Al-Noor Ramji to its board of directors.

Key Points: 
  • TORONTO, June 07, 2022 (GLOBE NEWSWIRE) -- Zafin , the worlds leading SaaS cloud-native product and pricing platform, has announced the addition of industry expert Al-Noor Ramji to its board of directors.
  • Financial institutions are contending with many headwinds, which is why theyre turning to partners like Zafin to help them become nimble and gain a competitive advantage, said Al-Noor Ramji.
  • To learn more about Zafin, please visit: https://zafin.com/
    Zafin is the global leader in SaaS cloud-native product and pricing solutions.
  • Zafin works with more than 450 institutions globally whose assets range in size from $200 million to $3 trillion.

SpectrumX Appoints Chief Financial Officer and Non-Executive Director

Retrieved on: 
Tuesday, March 22, 2022

SpectrumX, a UK-based healthcare and pharmaceutical company, is pleased to announce it has appointed Barry Saint as Chief Financial Officer and Debra Leeves as Non-Executive Director as the company progresses towards its IPO.

Key Points: 
  • SpectrumX, a UK-based healthcare and pharmaceutical company, is pleased to announce it has appointed Barry Saint as Chief Financial Officer and Debra Leeves as Non-Executive Director as the company progresses towards its IPO.
  • Prior to that, he served as Global Director of Corporate Finance and Group Treasurer of FTSE-250 speciality pharmaceuticals group, Indivior, which was formed through a $1.4 billion demerger from Reckitt Benckiser.
  • Barry Saint, Chief Financial Officer of SpectrumX, commented: I am delighted to have joined SpectrumX at this crucial stage as we prepare for IPO and then life as a listed company.
  • Debra Leeves, Non-Executive Director of SpectrumX, added: SpectrumX is developing ground-breaking treatments for patients across the world and I am excited to be joining as the company pushes forward the market roll out of its proprietary HOCI formulations.

ITSI ANNOUNCES GLOBAL ADVISORY BOARD

Retrieved on: 
Thursday, March 10, 2022

LONDON, March 10, 2022 /PRNewswire/ -- The Institute for Emerging Technologies & Social Impact (ITSI) is delighted to welcome Lord Anthony St John and William Je to its newly established Global Advisory Board.

Key Points: 
  • LONDON, March 10, 2022 /PRNewswire/ -- The Institute for Emerging Technologies & Social Impact (ITSI) is delighted to welcome Lord Anthony St John and William Je to its newly established Global Advisory Board.
  • The board will help to support and shape the next stage of ITSI's evolution.
  • Founded in 2021 by entrepreneur and investor Mileson Qiang Guo, ITSI is committed to the effective application of new technologies to the enhancement of free societies and in connecting those who share its vision.
  • He is the Founder and CEO of Hamilton Investment Management Ltd, a global fund manager with multi-billion assets under management.